{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T22:50:38Z","timestamp":1789253438286,"version":"build-2803163510"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human papillomavirus (HPV), a major cause of cervical cancer, typically remains localized to the cervix. However, there is limited understanding of whether this localized infection is associated with systemic immune responses in asymptomatic women, beyond the immediate cervical microenvironment. This study aimed to assess whether systemic immune-inflammation markers are linked to HPV infection and HPV-related cytological abnormalities in asymptomatic women undergoing health screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study included women from the Kangbuk Samsung Health Study who underwent HPV DNA testing and cervical cytology between 2016 and 2022. Participants were categorized as H0C0 (HPV-negative and normal cytology), H1C0 (HPV-positive and normal cytology), and H1C1 (HPV-positive and abnormal cytology, defined as low-grade abnormalities, including atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions). Systemic immune-inflammation markers, including white blood cell\u2013derived indices, high-sensitivity C-reactive protein, systemic inflammation response index (SIRI), lymphocyte-to-monocyte ratio (LMR), and neutrophil-to-monocyte ratio (NMR), were analyzed. Multinomial logistic regression was used to estimate the odds ratios (ORs) by biomarker quintiles and per 1-standard deviation (SD) increase.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 145 889 women (mean age 40.4 years), 6535 were classified as H1C0 and 2820 were classified as H1C1. Individuals with higher monocyte counts (Q5 vs Q1) had a significantly higher risk of H1C0 (OR = 1.14, 95% confidence interval [CI]: 1.06\u20131.24) and H1C1 (OR = 1.22, 95% CI: 1.08\u20131.37). Similarly, SIRI was positively associated with HPV infection status, with increasing odds for both H1C0 and H1C1 compared with H0C0, whereas LMR and NMR were inversely associated with H1C1. Per 1-SD increase, LMR was inversely associated with both H1C0 (OR = 0.71, 95% CI: 0.59\u20130.87) and H1C1 (OR = 0.48, 95% CI: 0.35\u20130.65), while monocyte count showed a positive association.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Human papillomavirus infection was associated with systemic immune\u2013inflammatory changes, most notably elevated monocyte count and related indices, even in individuals without cytological abnormalities. These findings highlight the potential relevance of monocyte-related markers for capturing the systemic immune effects of HPV infection beyond localized cervical changes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag194","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T11:42:59Z","timestamp":1775216579000},"source":"Crossref","is-referenced-by-count":1,"title":["Systemic Immune-Inflammation Markers Associate With Cervical Human Papillomavirus Infection in Asymptomatic Women"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4739-6607","authenticated-orcid":false,"given":"Myung-Gun","family":"Cho","sequence":"first","affiliation":[{"name":"Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University , Seoul ,","place":["South Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6945-9050","authenticated-orcid":false,"given":"Yoosoo","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University , Seoul ,","place":["South Korea"]},{"name":"Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine , Seoul ,","place":["South Korea"]},{"name":"Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine , Seoul ,","place":["South Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3927-8646","authenticated-orcid":false,"given":"Seungho","family":"Ryu","sequence":"additional","affiliation":[{"name":"Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University , Seoul ,","place":["South Korea"]},{"name":"Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine , Seoul ,","place":["South Korea"]},{"name":"Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine , Seoul ,","place":["South Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"2026041703021806300_ofag194-B1","author":"WHO"},{"key":"2026041703021806300_ofag194-B2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-3-031-33851-9_17","volume-title":"Global health essentials","author":"Tanzi","year":"2023"},{"key":"2026041703021806300_ofag194-B3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/ijgc-2022-003703","article-title":"Updates on cervical cancer prevention","volume":"33","author":"Viveros-Carre\u00f1o","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"2026041703021806300_ofag194-B4","doi-asserted-by":"crossref","first-page":"1591297","DOI":"10.3389\/fimmu.2025.1591297","article-title":"Immune responses to human papillomavirus infection and vaccination","volume":"16","author":"Kiamba","year":"2025","journal-title":"Front Immunol"},{"key":"2026041703021806300_ofag194-B5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/1547691X.2020.1755397","article-title":"Circulating inflammatory markers in cervical cancer patients and healthy controls","volume":"17","author":"Vitkauskaite","year":"2020","journal-title":"J Immunotoxicol"},{"key":"2026041703021806300_ofag194-B6","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/ijc.28119","article-title":"Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study","volume":"133","author":"Scott","year":"2013","journal-title":"Int J Cancer"},{"key":"2026041703021806300_ofag194-B7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/eurheartj\/ehad829","article-title":"Human papilloma virus and atherosclerotic cardiovascular disease","volume":"45","author":"Chan","year":"2024","journal-title":"Eur Heart J"},{"key":"2026041703021806300_ofag194-B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ihj.2024.02.001","article-title":"Unveiling HPV's hidden link: cardiovascular diseases and the viral intrigue","volume":"76","author":"Dutta","year":"2024","journal-title":"Indian Heart J"},{"key":"2026041703021806300_ofag194-B9","doi-asserted-by":"crossref","first-page":"e2300380","DOI":"10.1200\/GO.23.00380","article-title":"Association between cervical inflammatory mediators and prevalent cervical human papillomavirus infection","volume":"10","author":"Olukomogbon","year":"2024","journal-title":"JCO Glob Oncol"},{"key":"2026041703021806300_ofag194-B10","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/IGC.0b013e3181e513e5","article-title":"Association between Serum cytokine profiles and clearance or persistence of high-risk human papillomavirus infection: a prospective study","volume":"20","author":"Hong","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"2026041703021806300_ofag194-B11","doi-asserted-by":"crossref","first-page":"e0248639","DOI":"10.1371\/journal.pone.0248639","article-title":"IL-6 and IL-10 in the serum and exfoliated cervical cells of patients infected with high-risk human papillomavirus","volume":"16","author":"Bonin-Jacob","year":"2021","journal-title":"PLoS One"},{"key":"2026041703021806300_ofag194-B12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1076029614531449","article-title":"White blood cell counts, leukocyte ratios, and eosinophils as inflammatory markers in patients with coronary artery disease","volume":"21","author":"Kounis","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"2026041703021806300_ofag194-B13","doi-asserted-by":"crossref","DOI":"10.5455\/njppp.2023.13.06292202328062023","article-title":"High-sensitivity C-reactive protein as a biomarker of cardiovascular events","author":"Pandya","year":"2023","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"2026041703021806300_ofag194-B14","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.3390\/biomedicines10112697","article-title":"Usefulness of complete blood count (CBC) to assess cardiovascular and metabolic diseases in clinical settings: a comprehensive literature review","volume":"10","author":"Seo","year":"2022","journal-title":"Biomedicines"},{"key":"2026041703021806300_ofag194-B15","first-page":"321","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"2026041703021806300_ofag194-B16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.23736\/S0026-4784.19.04397-1","article-title":"Global strategies for cervical cancer prevention and screening","volume":"71","author":"Pimple","year":"2019","journal-title":"Minerva Ginecol"},{"key":"2026041703021806300_ofag194-B17","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/dom.15466","article-title":"Baseline and change in serum uric acid level over time and resolution of nonalcoholic fatty liver disease in young adults: the Kangbuk Samsung Health Study","volume":"26","author":"Cho","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2026041703021806300_ofag194-B18","doi-asserted-by":"crossref","first-page":"606335","DOI":"10.3389\/fonc.2020.606335","article-title":"Human papillomavirus-negative cervical cancer: a comprehensive review","volume":"10","author":"Xing","year":"2020","journal-title":"Front Oncol"},{"key":"2026041703021806300_ofag194-B19","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.jacc.2014.03.042","article-title":"Metabolically-healthy obesity and coronary artery calcification","volume":"63","author":"Chang","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026041703021806300_ofag194-B20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M15-1323","article-title":"Metabolically healthy obesity and development of chronic kidney disease: a cohort study","volume":"164","author":"Chang","year":"2016","journal-title":"Ann Intern Med"},{"key":"2026041703021806300_ofag194-B21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2021.02.009","article-title":"Metabolic syndrome and persistent cervical human papillomavirus infection","volume":"161","author":"Lee","year":"2021","journal-title":"Gynecol Oncol"},{"key":"2026041703021806300_ofag194-B22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5858\/2001-125-0391-TNHASX","article-title":"The new hematology analyzer Sysmex XE-2100: performance evaluation of a novel white blood cell differential technology","volume":"125","author":"Ruzicka","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"2026041703021806300_ofag194-B23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/v13020321","article-title":"Persistent human papillomavirus infection","volume":"13","author":"Della Fera","year":"2021","journal-title":"Viruses"},{"key":"2026041703021806300_ofag194-B24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10147-023-02337-7","article-title":"Carcinogenesis and management of human papillomavirus-associated cervical cancer","volume":"28","author":"Kusakabe","year":"2023","journal-title":"Int J Clin Oncol"},{"key":"2026041703021806300_ofag194-B25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.virol.2013.06.020","article-title":"High-risk human papillomavirus E6 inhibits monocyte differentiation to Langerhans cells","volume":"444","author":"Iijima","year":"2013","journal-title":"Virology"},{"key":"2026041703021806300_ofag194-B26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ijc.11411","article-title":"Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells","volume":"107","author":"Kleine-Lowinski","year":"2003","journal-title":"Int J Cancer"},{"key":"2026041703021806300_ofag194-B27","doi-asserted-by":"crossref","first-page":"e2537","DOI":"10.1002\/rmv.2537","article-title":"Human papillomavirus infection: epidemiology, biology, host interactions, cancer development, prevention, and therapeutics","volume":"34","author":"Wolf","year":"2024","journal-title":"Rev Med Virol"},{"key":"2026041703021806300_ofag194-B28","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3892\/ol.2015.2884","article-title":"Link between chronic inflammation and human papillomavirus-induced carcinogenesis (review)","volume":"9","author":"Fernandes","year":"2015","journal-title":"Oncol Lett"},{"key":"2026041703021806300_ofag194-B29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cytogfr.2016.03.007","article-title":"Inflammatory microenvironment and human papillomavirus-induced carcinogenesis","volume":"30","author":"Mangino","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"2026041703021806300_ofag194-B30","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3892\/etm.2017.4150","article-title":"Enhancement of humoral and cell mediated immune response to HPV16 L1-derived peptides subsequent to vaccination with prophylactic bivalent HPV L1 virus-like particle vaccine in healthy females","volume":"13","author":"Yokomine","year":"2017","journal-title":"Exp Ther Med"},{"key":"2026041703021806300_ofag194-B31","doi-asserted-by":"crossref","first-page":"863164","DOI":"10.3389\/fimmu.2022.863164","article-title":"Characterization of the early cellular immune response induced by HPV vaccines","volume":"13","author":"Pasmans","year":"2022","journal-title":"Front Immunol"},{"key":"2026041703021806300_ofag194-B32","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.3390\/jcm14145145","article-title":"Recent changes in sexually transmitted infection in Korea: a population-based analysis","volume":"14","author":"Song","year":"2025","journal-title":"J Clin Med"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofag194\/67929830\/ofag194.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/4\/ofag194\/68099341\/ofag194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/4\/ofag194\/68099341\/ofag194.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:02:34Z","timestamp":1776409354000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag194\/8625829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag194","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,30]]},"article-number":"ofag194"}}